Law360, New York (June 23, 2009) -- A Florida appellate court has held that state pharmacists cannot substitute Mylan Pharmaceuticals Inc.’s generic drug for Abbott Laboratories’ brand-name thyroid treatment Synthroid, finding that federal approval of a generic copycat does not override a state law barring the substitution of certain drugs.
In a unanimous opinion, the First District Court of Appeal in Florida determined on Monday that state law bans generic versions of certain drugs, including the drug that makes up...
